Skip to main content
. 2024 Mar 25;105(3):232–242. doi: 10.1159/000538319

Table 1.

Summary of 3 types of 5-ASA sustained-release oral formulations in Japan

Type of formulation
time-dependent pH-dependent MMX
Indication approved in Japan UC (except severe), CD UC (except severe) UC (except severe)
Regimen TID, BID, OD TID, OD OD
Maximum dose, mg/day 4,000 3,600 4,800
Tablets 250 mg, 500 mg 400 mg 1,200 mg
Granules 94% None None